Measles and rubella monitoring, February 2013
Measles and rubella are targeted for elimination in Europe by 2015. ECDC closely monitors progress towards interruption of endemic transmission of both diseases through enhanced surveillance and epidemic intelligence. Measles and rubella vaccinations are routinely delivered as trivalent measles-mumps-rubella (MMR) vaccine in Europe, and the first of the two recommended doses is normally given during the second year of life.
8 230 cases of measles were reported in EU/EEA countries in 2012, and rubella cases numbered 27 276. Whilst the number of measles cases is significantly lower than 2011 and 2010 it still continues to exceed the measles elimination target rate of less than one case per million people. The number of rubella cases, on the other hand, has jumped up from the 3 442 cases in the previous year.
This month’s Measles and Rubella monitoring report from ECDC reports on the latest surveillance data drawn from The European Surveillance System and carries analysis on the January to December 2012 period.
Measles cases are unsurprisingly low
The previous two years in EU/EEA countries have had around 30 000 reported cases of measles but in 2012 this number is down to 8 230. Four countries, France, Italy, Romania, Spain and the United Kingdom, accounted for 94% of the cases. This drop in measles cases, to pre-outbreak levels, is expected after a large scale outbreak where many of those previously susceptible have developed natural immunity as a result of the disease or supplementary vaccination activities.
Although it is good to see the number of cases in 2012 back to pre-outbreak levels, only twelve countries met the elimination target of less than one case of measles per million population during the last 12 months.
The 26 EU/EEA countries contributing to enhanced rubella surveillance reported 27 276 cases during the last 12-month period (January to December 2012). A number of countries have not reported data for December (and other months); including Romania, which accounts for 76% of all rubella cases for 2012. The outbreak in Poland accounts for a further 23% of cases.
Diphtheria - Annual Epidemiological Report for 2017
19 Jun 2019 - For 2017, 39 cases of diphtheria due to toxigenic Corynebacterium diphtheriae or C. ulcerans were reported to ECDC. The highest proportion of C. ulcerans cases was among adults 45 years of age and above, whereas C. diphtheriae cases were more common in younger age groups. Among C. diphtheriae cases, 50% were reported as imported. High vaccination coverage is crucial to prevent diphtheria.
Congenital toxoplasmosis – Annual Epidemiological Report for 2016
19 Jun 2019 - In 2016, 242 confirmed cases of congenital toxoplasmosis were reported in the EU/EEA, with France accounting for 81% of all confirmed cases due to the active screening of pregnant women. The notification rate was 6.7 cases per 100 000 live births. No seasonal pattern was observed for the disease.
Brucellosis – Annual Epidemiological Report for 2017
19 Jun 2019 - In 2017, 381 confirmed brucellosis cases were reported in the EU/EEA. The notification rate in the EU/EEA was 0.09 cases per 100 000 population. The highest rates were reported in southern EU Member States (Greece, Italy and Portugal). The highest rate was observed in 25–44-year-old males (0.16 per 100 000). The notification rate was stable from 2013–2017 in the EU/EEA.